Results 201 to 210 of about 1,471,493 (261)

Engineering Biology Beyond Single Genes: Advances and Challenges in Multiplex Genome Editing

open access: yesAnimal Research and One Health, EarlyView.
Multiplex genome editing is transforming genome engineering from single‐gene perturbation to network‐level control, yet its broader application remains limited by challenges in gRNA array engineering, delivery technologies, and safety management. Emerging AI‐driven approaches are accelerating guide RNA design and CRISPR effector optimization for ...
Linli Wang, Yongbin Liu, Hongbing Han
wiley   +1 more source

Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

open access: yesArthritis &Rheumatology, EarlyView.
Objective To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. Methods We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA ...
Outi Sareila   +12 more
wiley   +1 more source

Differences in SARS‐CoV‐2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER‐Adult Cohort Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post–acute COVID‐19 outcomes, though whether individuals with SARDs have longer persistence of viral antigens after COVID‐19 has not been studied.
Naomi J. Patel   +18 more
wiley   +1 more source

Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+‐Year Results From a Multicenter, Open‐Label Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner   +52 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Zoster Vaccine Live

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
Herpes zoster is a neurocutaneous disease caused by the varicella‐zoster virus and is associated with significant morbidity and long‐term sequelae in older adults. Until recently, treatment options for these complications have been primarily targeted at disease state management and symptom relief.
Denise R, Kockler, Michelle W, McCarthy
openaire   +2 more sources

The vaccine is dead – long live the vaccine

Trends in Parasitology, 2007
An important chapter in the search for a vaccine against malaria, that of the anti-Plasmodium falciparum vaccine candidate SPf66, has been effectively closed. A Cochrane review of ten major efficacy trials in endemic areas concluded it 'has little or no effect on preventing malaria'.
Georges, Snounou, Laurent, Rénia
openaire   +2 more sources

Influenza Vaccination with a Live Attenuated Vaccine

AJN, American Journal of Nursing, 2009
Influenza is a highly contagious, acute respiratory illness with a long history of outbreaks dating back several centuries. Although immunization is an effective means of protection against influenza, vaccination rates have been suboptimal, especially among certain high-risk groups, including children and health care personnel.
Michele, Michael   +4 more
openaire   +2 more sources

A Live Varicella Vaccine

1990
A live varicella vaccine has been developed, and its safety and immunogenicity have been established in normal children as well as in high-risk children.
M, Takahashi   +4 more
openaire   +2 more sources

LIVE ATTENUATED VARICELLA VACCINE

Annual Review of Microbiology, 1996
Varicella-zoster virus (VZV) is a ubiquitous human pathogen that causes varicella, commonly called chicken pox; establishes latency; and reactivates as herpes zoster, referred to as shingles. A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
A M, Arvin, A A, Gershon
openaire   +2 more sources

Poliomyelitis Vaccination with Live Poliovirus

Archives of Pediatrics & Adolescent Medicine, 1961
Until the year 1958, reports were available only on small numbers of persons vaccinated against poliomyelitis with live attenuated polio virus. Practically all information had been obtained from isolated or semi-isolated groups in institutions. Early in 1958, we began one of the first field trials with live polio vaccine, a controlled study of ...
F, BUSER, M, SCHAR
openaire   +2 more sources

Home - About - Disclaimer - Privacy